Abbas El Sahili

Chief Executive Officer Singzyme

Seminars

Wednesday 12th November 2025
Exploring Peptide Engineering for Improved Activity & Survival Alongside Radioisotopes
2:00 pm
  • Engineering peptides to improve tissue penetration and receptor binding, thereby increasing tumour uptake and retention of radioisotopes
  • Modifying peptide stability and clearance rates to extend half-life and reduce systemic toxicity, enhancing therapeutic efficacy.
  • Designing peptides to deliver radioisotopes directly to tumour sites, maximising localised radiation delivery and minimising damage to healthy tissues
Abbas Sahili, Chief Executive Officer, Singzyme